Jump to content

Hydrochlorothiazide/triamterene

From Wikipedia, the free encyclopedia
(Redirected from Maxzide)

Hydrochlorothiazide/triamterene
Combination of
HydrochlorothiazideThiazide diuretic
TriamterenePotassium-sparing diuretic
Clinical data
Trade namesDyazide, Maxzide, others
Other namesco-triamterzide
AHFS/Drugs.comProfessional Drug Facts
License data
Pregnancy
category
  • AU: C
Routes of
administration		By mouth
ATC code
Legal status
Legal status
Identifiers
CAS Number
KEGG

Hydrochlorothiazide/triamterene, also known as co-triamterzide, is a fixed-dose combination medication of hydrochlorothiazide and triamterene.[2][3][4] It is used to treat high blood pressure and edema (swelling).[2][3][4] Specifically it is used in those who develop low blood potassium (hypokalemia) when on only hydrochlorothiazide.[2][3] It is taken by mouth.[2][3][4]

Side effects may include nausea, trouble sleeping, dizziness, feeling light headed with standing, kidney problems, allergies, and muscle cramps.[2][3] Other serious side effects may include high blood potassium.[2][3] Use in pregnancy and breastfeeding is not generally recommended.[2][3] Use in those with significant kidney problems is not recommended.[2][3] It decreases blood pressure mainly by hydrochlorothiazide while triamterene decreases the amount of potassium lost.[2][3]

The combination was approved for medical use in the United States in 1965.[5] In 2022, it was the 116th most commonly prescribed medication in the United States, with more than 5 million prescriptions.[6][7]

References

[edit]
  1. ^ "FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA. Retrieved 22 October 2023.
  2. ^ a b c d e f g h i j "Dyazide- hydrochlorothiazide and triamterene capsule". DailyMed. 31 October 2017. Retrieved 20 August 2020.
  3. ^ a b c d e f g h i j "Maxzide-25- maxzide tablet Maxzide tablet". DailyMed. 20 July 2018. Retrieved 20 August 2020.
  4. ^ a b c British national formulary : BNF 76 (76 ed.). Pharmaceutical Press. 2018. p. 76. ISBN 9780857113382.
  5. ^ "Dyazide: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Retrieved 20 August 2020.
  6. ^ "The Top 300 of 2022". ClinCalc. Archived from the original on 30 August 2024. Retrieved 30 August 2024.
  7. ^ "Hydrochlorothiazide; Triamterene Drug Usage Statistics, United States, 2013 - 2022". ClinCalc. Retrieved 30 August 2024.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Hydrochlorothiazide/triamterene&oldid=1248548771"